Schedule 13G ownership disclosure

CYCLERION THERAPEUTICS INC

Common Stock, no par value · CUSIP: 23255M204

Event date: 2024-11-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Slate Path Capital LP

    Shares: 0.00 · Class: 0%

  • David Greenspan

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006852
Form type
SCHEDULE 13G/A
Filer
Korsana Biosciences, Inc.
CIK
CIK 1755237
Filed
Dec 06, 2024
Reporting period
Nov 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub